BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14666716)

  • 1. Combined effects of resveratrol and paclitaxel on lung cancer cells.
    Kubota T; Uemura Y; Kobayashi M; Taguchi H
    Anticancer Res; 2003; 23(5A):4039-46. PubMed ID: 14666716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells.
    Kim YA; Lee WH; Choi TH; Rhee SH; Park KY; Choi YH
    Int J Oncol; 2003 Oct; 23(4):1143-9. PubMed ID: 12963997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines.
    Cheng H; An SJ; Zhang XC; Dong S; Zhang YF; Chen ZH; Chen HJ; Guo AL; Lin QX; Wu YL
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):637-46. PubMed ID: 20495920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
    Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
    Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).
    Sugiyama K; Akiyama T; Shimizu M; Tamaoki T; Courage C; Gescher A; Akinaga S
    Cancer Res; 1999 Sep; 59(17):4406-12. PubMed ID: 10485490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells.
    Hsu YL; Kuo PL; Lin CC
    Life Sci; 2004 Jul; 75(10):1231-42. PubMed ID: 15219811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HY253, a novel decahydrofluorene analog, from Aralia continentalis, induces cell cycle arrest at the G1 phase and cytochrome c-mediated apoptosis in human lung cancer A549 cells.
    Oh HL; Lee DK; Lim H; Lee CH
    J Ethnopharmacol; 2010 May; 129(1):135-9. PubMed ID: 20219657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
    Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
    Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-independent apoptosis induced by genistein in lung cancer cells.
    Lian F; Li Y; Bhuiyan M; Sarkar FH
    Nutr Cancer; 1999; 33(2):125-31. PubMed ID: 10368806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
    Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
    Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics.
    Rosetti M; Zoli W; Tesei A; Ulivi P; Fabbri F; Vannini I; Brigliadori G; Granato AM; Amadori D; Silvestrini R
    J Cell Physiol; 2007 Sep; 212(3):710-6. PubMed ID: 17458894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
    Zhang D; Qiu L; Jin X; Guo Z; Guo C
    Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells.
    Weng CJ; Yang YT; Ho CT; Yen GC
    J Agric Food Chem; 2009 Jun; 57(12):5235-43. PubMed ID: 19441815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
    Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP
    Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells.
    Lee EJ; Min HY; Joo Park H; Chung HJ; Kim S; Nam Han Y; Lee SK
    Life Sci; 2004 Oct; 75(23):2829-39. PubMed ID: 15464834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.